Injective INJ
Current Price
$4.68 -9.55%
$0.6700 Daily Range (14.32%)
$4.60$5.27
$73.23M Daily Volume
789 BTC
Vol/MktCap: 15.68%
Market Performance
0.17% Relative BTC Volume
The total volume of Injective is $73.23M over the past 24 hours, compared to $43.17B total Bitcoin volume.
Hourly Moving Average
8 SMA $4.67 +0.16%
13 SMA $4.70 -0.40%
21 SMA $4.89 -4.35%
55 SMA $5.16 -9.23%
144 SMA $5.29 -11.60%
Price Performance
+0.69% 1 Hour Change
$4.68 from $4.65
-7.78% 7 Day Change
-$0.3640 from $5.04
-8.82% 14 Day Change
-$0.4126 from $5.09
-2.85% 30 Day Change
-$0.1335 from $4.81
All Time High
March 14, 2024
$52.62 -91.11%
-$47.94 vs. now
24H Change
-49.92M USD -9.66%
-538 BTC
Volume and Supply
Total Supply: 100.00M INJ 
100.00M INJ Available100.00% circulating A lower circulating supply may increase over time, reducing scarcity and potentially causing a drop in price. A higher circulating supply is less susceptible to dilution, offering the potential for a more stable price long-term.
Relative Supply Ratio
5.01 x BTC Supply5:1 supply ratio
RSR reflects potential differences in tokenomics, such as inflation rates, utility, or burn mechanisms, which can impact long-term value and scarcity.
Relative Trade Volume
14.84M INJ
traded over past 24 hours
14.84% of circulating supply
A higher trade volume relative to market cap indicates strong market activity and liquidity, while a lower ratio may suggest reduced interest, lower liquidity, or potential price stagnation.
Conversion Tool
Injective AI Market Analysis
Injective (INJ) is currently priced at $4.67, reflecting a significant decline of 10.27% over the past 24 hours. The daily trading range has been relatively tight, between a high of $5.27 and a low of $4.60, indicating a lack of bullish momentum.
The trading volume stands at approximately $71.19 million, contributing to a volume-to-market cap ratio of 15.24%. This suggests moderate market activity, but the substantial drop in price could be a reaction to recent selling pressure rather than healthy accumulation.
Technical indicators show an alarming 1-hour RSI at 21, indicating oversold conditions, while the 7-day RSI at 45 suggests potential for a short-term recovery if buying interest emerges. However, the short-term moving averages (8 SMA at $4.85, 13 SMA at $4.99) are trending downward, indicating continued bearish sentiment.
The longer-term moving averages also reflect bearish pressure, with the 55 SMA at $5.24 and the 144 SMA at $5.32 indicating that resistance levels are well above the current price. The overall trend has been negative, with 7-day, 14-day, and 30-day price changes at -7.85%, -9.55%, and -3.66% respectively, pointing to a consistent downtrend.
Injective’s all-time high was $52.62 in March 2024, significantly distant from the current price, raising concerns about the sustainability of its previous levels. While the oversold RSI could indicate a potential short-term bounce, the prevailing bearish trend suggests caution.
Given the current technical setup, including the declining moving averages and negative price momentum, a Sell rating is warranted. Investors should consider waiting for clearer bullish signals or a more favorable entry point before re-entering this asset.
The trading volume stands at approximately $71.19 million, contributing to a volume-to-market cap ratio of 15.24%. This suggests moderate market activity, but the substantial drop in price could be a reaction to recent selling pressure rather than healthy accumulation.
Technical indicators show an alarming 1-hour RSI at 21, indicating oversold conditions, while the 7-day RSI at 45 suggests potential for a short-term recovery if buying interest emerges. However, the short-term moving averages (8 SMA at $4.85, 13 SMA at $4.99) are trending downward, indicating continued bearish sentiment.
The longer-term moving averages also reflect bearish pressure, with the 55 SMA at $5.24 and the 144 SMA at $5.32 indicating that resistance levels are well above the current price. The overall trend has been negative, with 7-day, 14-day, and 30-day price changes at -7.85%, -9.55%, and -3.66% respectively, pointing to a consistent downtrend.
Injective’s all-time high was $52.62 in March 2024, significantly distant from the current price, raising concerns about the sustainability of its previous levels. While the oversold RSI could indicate a potential short-term bounce, the prevailing bearish trend suggests caution.
Given the current technical setup, including the declining moving averages and negative price momentum, a Sell rating is warranted. Investors should consider waiting for clearer bullish signals or a more favorable entry point before re-entering this asset.
Updated 145 minutes ago.
Injective Relative Price at Market Cap of:
Injective TradingView Chart
In The News

Decentraland joins GameFi rebound – MANA’s move to $0.20 depends on…
The dormant circulation saw a sizeable spike on Sunday, showing older coins were moved onchain, likely for selling.

Avalanche price prediction 2026-2032: Time to buy AVAX?
Avalanche price prediction 2025-2031: Time to buy AVAX?

Micron says the global memory chip shortage is getting worse and will last beyond this year
Micron says the world is heading into a serious memory chip shortage that’s not going to fix itself literally anytime soon.

US Senate panel wants developer safeguards out of crypto bill
The Republican and Democratic Senate Judiciary leaders have called for changes to the market structure bill, arguing it would “weaken” the ability to police money transmitters.